`
Thursday, 17 August 2017

Biologics News

  • Singapore regulatory grants cGMP certificate to Lonza

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 21 Apr, 2014

    Singapore: Biologics manufacturing global firm, Lonza Bioscience, has received cGMP certification from Singapore Health Sciences Authority (HSA). The audit/conformity assessment, performed...Read more

  • NUS, Thermo Fisher Scientific strike alliance

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2014

    Singapore: National University of Singapore (NUS) and Life Sciences Group of Thermo Fisher Scientific have struck a strategic alliance of a three to five year programme, to advance fundamen...Read more

  • China Biologic's subsidiary signs plasma sourcing deal

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2015

    Singapore: Guizhou Taibang Biological Products, subsidiary of China Biologic Product, has collaborated  with Xinjiang Deyuan Bioengineering to source raw plasma. The agreement allows Guiz...Read more

  • Medicago, Mitsubishi to co-cultivate plants

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 31 Jan, 2013

    Singapore: Medicago is collaborating with Mitsubishi Chemical to evaluate the latter's closed cultivation Plant Factory System to produce Nicotiana Benthamiana plants for protein production...Read more

  • WuXi Biologics to build world's largest biologics facility

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 05 May, 2015

    Singapore: Wuxi Biologics, a wholly owned subsidiary of China-based WuXi PharmaTech, recently announced that it has begun the construction of a new $150 million biologics manufacturing faci...Read more

  • Samsung JV seeks second biosimilar approval in Europe

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2015

    Singapore: Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, has submitted marketing authorization application (MAA) for SB2, its Remicade (Infliximab) biosimilar ...Read more

  • Merck, China firm to co-develop DNA repair drug

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013

    ‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, and commercialization agreement with BeiGene, a biotech R&D compa...Read more

  • Austrinova opens new facility in Singapore

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2015

    Singapore: Singapore based biotech firm, Austrianova, has opened a new facility in Singapore to perform research and development and translational research activities for its cell encapsula...Read more

  • China Biologic subisdiary gets GMP tag

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Dec, 2014

    Singapore: Plasma-based biopharmaceutical company, China Biologic Products' subsidiary firm, Shandong Taibang Biological Products has received Good Manufacturing Practices certification fro...Read more

  • NUS team pioneers a novel technique to deliver biologicals

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2014

    Singapore: Researchers at the National University of Singapore have invented a novel technique to administer pain-killers and collagen into the body through a minimally invasive procedure. ...Read more

  • Hope for COPD: Network Verification Challenge

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2014

    Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chronic obstructive pulmonary disease (COPD) which are now available for re...Read more

  • Amgen unveils new plant in Asia

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Nov, 2014

    Singapore: US-based Amgen enters the Asian market with its new 'next-generation' biomanufacturing facility in Singapore. The plant is located in Tuas Biomedical Park. It will maufacture a m...Read more

  • A*STAR, Japanese bank ink partnership

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2014

    Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporation (SMBC) have inked a memorandum of understanding (MOU) to support ...Read more

  • AmpliPhi, SPH to combat antibiotic-resistant super bugs

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2012

    Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (SPS). The combination of the two companies would result in the creati...Read more

  • FUJIFILM expands cell manufacturing capacity

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2014

    Singapore: Gobal contract manufacturing firm, FUJIFILM Diosynth Biotechnologies, has expanded its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreacto...Read more

  • Biocon starts academy to train biotech professionals

    Biologics |  News | By Narayanan Suresh | 0 Comment | 12 Nov, 2013

    Bangalore: In a first for Asia's bioscience industry, India's leading biotech company, Biocon has started an academy to train biotech professional for the Indian and global industry in asso...Read more

  • Molecular painting sparks biologics research

    Biologics |  Influencers | By Amrita Tejasvi | 0 Comment | 01 Aug, 2012

    At the University of Veterinary Medicine in Vienna, Austria, Dr John Dangerfield and Dr Brian Salmons along with Dr Christoph Metzner developed a technology for quick and easy modification ...Read more

  • Making kidney dialysis cheaper and quicker

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2016

    Singapore: Scientists at the Indian Institute of Technology- Bombay, India have developed a unique membrane that can effectively reduce dialysis time and cut costs to almost 50 percent. The...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls